Hypoxia Studies with Pimonidazole in vivo, Bioprotocol, vol.4, 2014. ,
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2), Lancet, issue.9972, pp.977-1010, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01912088
Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment, Stem Cells International, pp.1-17, 2017. ,
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature, vol.444, issue.7119, pp.633-637, 2006. ,
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors, Nature Genetics, vol.40, issue.5, pp.499-507, 2008. ,
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer, Biochemical and biophysical research communications, vol.385, issue.3, pp.307-320, 2009. ,
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity, Nature Medicine, vol.16, issue.7, pp.781-787, 2010. ,
High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells, Cancer Research, vol.70, issue.13, pp.5399-5408, 2010. ,
Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice, Journal of Bone and Mineral Research, vol.27, pp.2118-2129, 2012. ,
Sarcoma classification: An update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone, Cancer, vol.120, issue.12, pp.1763-1774, 2014. ,
Understanding cancer from the stem cells up, Nature Medicine, vol.23, issue.6, pp.656-657, 2017. ,
Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines, International journal of oncology, vol.34, issue.5, pp.1381-1387, 2009. ,
A proposed quantitative index for assessing the potential contribution of reprogramming to cancer stem cell kinetics, Stem cells international, p.249309, 2014. ,
Autophagy maintains stemness by preventing senescence, Nature, vol.529, issue.7584, pp.37-42, 2016. ,
Stem-like cells in bone sarcomas: implications for tumorigenesis, Neoplasia, vol.7, issue.11, pp.967-76, 2005. ,
Genomics Law Governs Clinical Behavior of Human Cancer: Implications for Decision Making in Disease Management, Journal of Clinical Oncology, vol.26, issue.17, pp.2846-2853, 2008. ,
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells, Breast Cancer Research, vol.10, issue.3, 2008. ,
CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study, vol.4, pp.435-441, 2012. ,
Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects, Journal of the National Cancer Institute, vol.93, issue.4, pp.266-76, 2001. ,
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4, Science, issue.6255, p.5612, 2015. ,
Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, vol.17, issue.1, pp.248-53, 2017. ,
RNA sequencing validation of the Complexity INdex in SARComas prognostic signature, European Journal of Cancer, vol.57, pp.104-111, 2016. ,
miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1, Oncotarget, vol.7, issue.12, pp.13491-501, 2016. ,
Cancer stem cells: impact, heterogeneity, and uncertainty, Cancer cell, vol.21, issue.3, pp.283-96, 2012. ,
Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma, International journal of cancer, vol.130, issue.11, pp.2514-2539, 2012. ,
HIF induces human embryonic stem cell markers in cancer cells, Cancer research, vol.71, issue.13, pp.4640-52, 2011. ,
Calpain-6 confers atherogenicity to macrophages by dysregulating premRNA splicing, The Journal of clinical investigation, vol.126, issue.9, pp.3417-3449, 2016. ,
Tackling the cancer stem cells ? what challenges do they pose?, Nature Reviews Drug Discovery, vol.13, issue.7, pp.497-512, 2014. ,
HIF-2? Regulates NANOG Expression in Human Embryonic Stem Cells following Hypoxia and Reoxygenation through the Interaction with an Oct-Sox Cis Regulatory Element, PLoS ONE, vol.9, issue.10, p.108309, 2014. ,
Autophagy plays an important role in stemness mediation and the novel dual function of EIG121 in both autophagy and stemness regulation of endometrial carcinoma JEC cells, International Journal of Oncology, vol.51, issue.2, pp.644-656, 2017. ,
Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis, Cancer letters, vol.271, issue.2, pp.306-319, 2008. ,
Cancer: Crime and punishment, Nature, vol.436, issue.7051, pp.636-637, 2005. ,
Identification of Cancer Stem Cells in Ewing's Sarcoma, Cancer Research, vol.69, issue.5, pp.1776-1781, 2009. ,
Calpain-6, a microtubule-stabilizing protein, regulates Rac1 activity and cell motility through interaction with GEF-H1, Journal of cell science, vol.124, pp.1214-1237, 2011. ,
Calpain-6 Deficiency Promotes Skeletal Muscle Development and Regeneration, PLoS Genetics, vol.9, issue.8, pp.1-11, 2013. ,
Calpain-6 deficiency promotes skeletal muscle development and regeneration, PLoS genetics, vol.9, issue.8, p.1003668, 2013. ,
Calpain 6 is involved in microtubule stabilization and cytoskeletal organization, Molecular and cellular biology, vol.27, issue.7, pp.2548-61, 2007. ,
Cancer stem cell definitions and terminology: the devil is in the details, Nature Reviews Cancer, vol.12, issue.11, pp.767-775, 2012. ,
Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in Human Embryonic Stem Cell Self-Renewal, Developmental Cell, vol.25, issue.1, pp.69-80, 2013. ,
Autophagy regulates the stemness of cervical cancer stem cells, Biologics: Targets and Therapy, vol.11, pp.71-79, 2017. ,
Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer, Molecular and Cellular Biology, pp.352-369, 2017. ,
Multilineage embryonic hematopoiesis requires hypoxic ARNT activity, Genes and Development, vol.13, issue.19, pp.2478-2483, 1999. ,
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance, Cancer Research, vol.70, issue.11, pp.4602-4614, 2010. ,
Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci, vol.100, 2003. ,
Pronostic impact of P53 status in Ewing sarcoma, Cancer, issue.89, pp.783-792, 2000. ,
Bone microenvironment signals in osteosarcoma development, Cellular and Molecular Life Sciences, vol.72, issue.16, pp.3097-3113, 2015. ,
,
, , vol.385, pp.62038-62047, 2016.
Jekyll and Hyde: The role of the microenvironment on the progression of cancer, Journal of Pathology, vol.223, issue.2, pp.162-176, 2011. ,
,
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours, Journal of Pathology, vol.224, issue.3, pp.334-343, 2011. ,
Molecular variants of EWS-WT1 gene fusion in desmoplastic small round cell tumor, Diagn Mol Pathol, issue.7, pp.24-28, 1998. ,
Stemness in cancer: Stem cells, cancer stem cells, and their microenvironment, Stem Cells International, 2017. ,
Epigenetic Control of Embryonic Stem Cell Differentiation, Stem Cell Reviews and Reports, vol.8, issue.1, pp.67-77, 2012. ,
High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-Fli1 inhibition, PLoS ONE, issue.11, p.5, 2010. ,
,
Fearful symmetry: Subversion of asymmetric division in cancer development and progression, Cancer Research, vol.75, issue.5, pp.792-797, 2015. ,
Ewing's sarcoma, The Lancet Oncology, vol.11, issue.2, pp.184-192, 2010. ,
Moving Forward in Human Mammary Stem Cell Biology and Breast Cancer Prognostication Using ALDH1, Cell Stem Cell, vol.1, issue.5, pp.485-487, 2007. ,
,
Regulation of chromatin by histone modifications, Cell Research, vol.21, issue.3, pp.381-395, 2011. ,
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors, Nature Genetics, vol.40, issue.5, pp.499-507, 2008. ,
Asymmetric cell division of stem cells in the lung and other systems, Frontiers in Cell and Developmental Biology, vol.2, p.33, 2014. ,
ER stressregulated translation increases tolerance to extreme hypoxia and promotes tumor growth, The EMBO Journal, vol.24, issue.19, pp.3470-3481, 2005. ,
,
Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good respons, Journal of Clinical Oncology, vol.33, issue.20, pp.2279-2287, 2015. ,
Establishment of a patient-derived orthotopic osteosarcoma mouse model, Journal of Translational Medicine, vol.13, issue.1, p.136, 2015. ,
A family of drug transporters: the multidrug resistance-associated proteins, Journal of the National Cancer Institute, vol.92, issue.16, pp.1295-1302, 2000. ,
Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and beta 1-integrin in conventional osteosarcoma, Oncotarget, vol.7, issue.40, pp.64702-64710, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01482390
Cancer stem cells in osteosarcoma, Cancer Letters, vol.386, pp.189-195, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01466078
Local effects of malignancy on bone, Curr Opin Endocrinol Diabetes Obes, 2007. ,
Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells, Cell Death & Disease, vol.3, issue.12, 2012. ,
, Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, Cancer Genome Atlas Research Network, vol.368, issue.22, pp.2059-2074, 2013.
Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, Ewing sarcoma-like tumors, Cancer Research, vol.65, issue.19, pp.8698-8705, 2005. ,
Amplification of the c-myc proto-oncogene in human chondrosarcoma, Diagn Mol Pathol, 1992. ,
Experimental evidence for a neural origin of Ewing's sarcoma of bone, The American Journal of Pathology, vol.127, issue.3, pp.507-525, 1987. ,
The transcriptional foundation of pluripotency, Development, issue.14, pp.2311-2333, 2009. ,
,
ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program, Cancer Research, vol.73, issue.24, pp.7290-7300, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01431937
ALDH1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer, Clinical Cancer Research, vol.16, issue.1, pp.45-55, 2010. ,
Zfp143 Regulates Nanog Through Modulation of Oct4 Binding, Stem Cells, vol.26, issue.11, pp.2759-2767, 2008. ,
,
,
Side population purified from hepatocellular carcinoma cells harbors cancer stem celllike properties, Hepatology, vol.44, issue.1, pp.240-251, 2006. ,
, Hedgehog Signaling. Vitamins and Hormones, 2012.
,
445Odose-Escalation Study of Sonidegib (Lde225) Plus Buparlisib (Bkm120) in Patients (Pts) With Advanced Solid Tumors, Annals of Oncology, vol.25, issue.suppl_4, pp.147-148, 2014. ,
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor, PLoS Biology, vol.6, issue.12, 2008. ,
Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma, Cancer Research, vol.74, issue.22, pp.6610-6622, 2014. ,
Polycomb genes and cancer: Time for clinical application?, Critical Reviews in Oncology, vol.83, issue.2, pp.184-193, 2012. ,
The calpains: modular designs and functional diversity, Genome Biology, vol.8, issue.6, 2007. ,
A New Subfamily of Vertebrate Calpains Lacking a Calmodulin-Like Domain : Implications for Calpain Regulation and Evolution, vol.184, pp.175-184, 1997. ,
Diverse mRNA expression patterns of the mouse calpain genes Capn5, Capn6 and Capn11 during development, Mechanisms of Development, vol.89, issue.1-2, pp.201-209, 1999. ,
Capturing Chromosome Conformation, Science, vol.295, issue.5558, pp.1306-1311, 2002. ,
Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation, Cancer Cell, vol.14, issue.3, pp.238-249, 2008. ,
ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells, Stem Cells and Development, vol.18, issue.1, pp.17-26, 2009. ,
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression, Cancer Cell, vol.30, issue.4, pp.533-547, 2016. ,
,
,
Understanding cancer from the stem cells up, Nature Medicine, vol.23, issue.6, pp.656-657, 2017. ,
Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium, The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society, vol.60, issue.9, pp.675-82, 2012. ,
Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal, Cancer Cell International, vol.13, issue.1, 2013. ,
Diffuse endothelioma of bone, Proc New York Path, vol.21, pp.17-24, 1921. ,
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors, Cancer Research, vol.66, issue.15, pp.7445-7452, 2006. ,
Mammary stem cells and breast cancer--role of Notch signalling, Stem Cell Rev, 2007. ,
Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma, Clinical Science, vol.110, issue.6, pp.645-54, 1979. ,
, , 2003.
, Prostate Cancer Cells-Osteoblast Interaction Shifts Expression of Growth / Survivalrelated Genes in Prostate Cancer and Reduces Expression of Osteoprotegerin in Osteoblasts Prostate Cancer Cells-Osteoblast Interaction Shifts Expression of Growth / Surviv, vol.9, pp.2587-2597
World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Soft Tissue and Bone, vol.177, pp.1365-76, 2002. ,
Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia, Cell Death and Disease, vol.8, issue.7, 2017. ,
Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton, Virchows Archiv, 1998. ,
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, vol.45, pp.89-95, 2016. ,
Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells, Stem Cells International, 2016. ,
Autophagy maintains stemness by preventing senescence, Nature, vol.529, issue.7584, pp.37-42, 2016. ,
, The Clinical Approach Towards Chondrosarcoma LEARNING OBJECTIVES, pp.320-329, 2016.
Stem-like cells in bone sarcomas: implications for tumorigenesis, Neoplasia, vol.7, issue.11, pp.967-76, 2005. ,
,
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome, Cell Stem Cell, vol.1, issue.5, pp.555-567, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01431968
EZH2 expands breast stem cells through activation of NOTCH1 signaling, Proceedings of the National Academy of Sciences, vol.111, issue.8, pp.3098-3103, 2014. ,
,
Endothelin-1 mediates intermittent hypoxia-induced inflammatory vascular remodeling through HIF-1 activation, Journal of Applied Physiology, vol.120, issue.4, pp.437-443, 2016. ,
Animal Models in Osteosarcoma, Frontiers in Oncology, vol.4, pp.1-7, 2014. ,
Hypoxia requires Notch signaling to maintain the undifferentiated cell state, Developmental Cell, vol.9, issue.5, pp.617-628, 2005. ,
Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance, Oncotarget, vol.8, issue.22, pp.36305-36318, 2017. ,
,
Hallmarks of cancer: The next generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
Characterization of a side population of cancer cells from human gastrointestinal system, Stem Cells, vol.24, issue.3, pp.506-513, 2006. ,
,
A distinct "side population" of cells with high drug efflux capacity in human tumor cells, Proceedings of the National Academy of Sciences of the United States of America, vol.101, issue.39, pp.14228-14261, 2004. ,
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells, Cancer Research, vol.67, issue.10, pp.4827-4833, 2007. ,
DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency, Cell Stem Cell, 2009. ,
Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation, Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol.26, issue.3, pp.657-65, 2011. ,
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance, pp.501-505, 2010. ,
EWS-FLI1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor, p.100, 1995. ,
Reduced Folate Carrier Protein Expression in Osteosarcoma: Implications for the Prediction of Tumor Chemosensitivity, Cancer, vol.98, issue.9, pp.1958-1966, 2003. ,
Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2, International Journal of Oncology, vol.40, issue.1, pp.71-79, 2012. ,
Distinct breast cancer stem/progenitor cell populations require either HIF1? or loss of PHD3 to expand under hypoxic conditions, Oncotarget, vol.6, issue.31, pp.31721-31760, 2015. ,
Therapeutic molecular targets in human chondrosarcoma, International Journal of Experimental Pathology, vol.91, issue.5, pp.387-393, 2010. ,
, , 2010.
,
, Osteosarcoma in very young children, Cancer, vol.116, issue.22, pp.5316-5324
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature, vol.479, issue.7374, pp.547-551, 2011. ,
Translational biology of osteosarcoma, vol.14, pp.722-735, 2014. ,
,
Autophagy at the crossroads of catabolism and anabolism, Nature Reviews Molecular Cell Biology, vol.16, issue.8, pp.461-472, 2015. ,
,
NBR 1 enables autophagy-dependent focal adhesion turnover, Journal of Cell Biology, vol.212, issue.5, pp.577-590, 2016. ,
Asymmetric cell division: recent developments and their implications for tumour biology, Nature Reviews. Molecular Cell Biology, vol.11, issue.12, pp.849-860, 2010. ,
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma, Pancreas, issue.0, pp.1-6, 2015. ,
,
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proceedings of the National Academy of Sciences of the United States of America, vol.101, issue.3, pp.781-787, 2004. ,
,
Hypoxia causes the activation of nuclear factor kappa through the phosphorilation of I-kB on tyrosine residues, Cancer Res, issue.54, pp.1425-1430, 1994. ,
CD99-Positive "'Ewing's Sarcoma"' from Mouse Bone Marrow-Derived Mesenchymal Progenitor Cells?, Cancer Research, vol.66, issue.19, pp.9786-9787, 2006. ,
Evolution of the cancer stem cell model, Cell Stem Cell, vol.14, issue.3, pp.275-291, 2014. ,
The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches, Drug Resistance Updates, vol.13, issue.4-5, pp.99-108, 2010. ,
Regulation of osteoprotegerin pro-or anti-tumoral activity by bone tumor microenvironment, Biochimica et Biophysica Acta -Reviews on Cancer, issue.1, pp.17-24, 2010. ,
,
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, vol.367, 1994. ,
The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide, Cancer Research, vol.58, issue.11, pp.2469-2476, 1998. ,
Cancer Metabolism: Fueling More than Just Growth, Molecules and Cells, vol.39, issue.12, pp.847-854, 2016. ,
,
Increased expression of calpain 6 during the progression of uterine cervical neoplasia: Immunohistochemical analysis, Oncology Reports, vol.19, issue.4, pp.859-863, 2008. ,
DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells, Oncology Letters, vol.14, issue.1, pp.171-179, 2017. ,
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma, Cancer Cell, vol.23, issue.6, pp.739-752, 2013. ,
Genetic and molecular abnormalities in tumors of the bone and soft tissues, Cancer Control, vol.8, issue.3, pp.239-251, 2001. ,
Chromatin modification and epigenetic reprogramming in mammalian development, Nature Reviews Genetics, vol.3, issue.9, pp.662-673, 2002. ,
Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells, Nature Cell Biology, vol.10, issue.6, pp.731-739, 2008. ,
Navigating the bone marrow niche: translational insights and cancer-driven dysfunction, Nature Reviews Rheumatol, vol.2, issue.74, pp.154-168, 2015. ,
Bone Sarcomas in Pediatrics : Progress in Our Understanding of Tumor Biology and Implications for Therapy, Pediatric Drugs, vol.17, issue.4, pp.257-271, 2015. ,
Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice, Carcinogenesis, vol.30, issue.10, pp.1789-1795, 2009. ,
The PI3K-Akt pathway regulates calpain 6 expression, proliferation, and apoptosis, Cellular Signalling, vol.23, issue.5, pp.827-836, 2011. ,
,
miR-449a promotes liver cancer cell apoptosis by down regulation of Calpain 6 and, vol.2, pp.13491-13501, 2015. ,
Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development, Cancer Cell, vol.30, issue.1, pp.92-107, 2016. ,
Calpains as potential anti-cancer targets, Expert Opin Ther Targets, vol.119, pp.5124-5136, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01740915
Aldehyde dehydrogenase its role as a cancer stem cell marker comes down to the specific isoform, Cell Cycle, vol.10, issue.9, pp.1378-1384, 2011. ,
Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma, International Journal of Cancer, vol.130, issue.11, pp.2514-2525, 2012. ,
Evaluation of selected cytokines in children and adolescents with osteosarcoma at diagnosis -preliminary report, Med Wieku Rozwoj, 2011. ,
Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line, BMC Cancer, vol.12, issue.1, p.139, 2012. ,
HIF induces human embryonic stem cell markers in cancer cells, Cancer Research, vol.71, issue.13, pp.4640-52, 2011. ,
Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation, vol.125, pp.629-639, 2015. ,
Mammalian Krueppel-Like Factors in Health and Diseases, Physiological Reviews, vol.90, 2010. ,
,
Metastasis: a question of life or death, Nature Reviews Cancer, vol.6, issue.6, pp.449-458, 2006. ,
Targeting Hedgehog -a Cancer Stem Cell Pathway, Clin Cancer Res, vol.86, issue.12, pp.3279-3288, 2010. ,
Does surgery or radiation provide the best overall survival in Ewing's sarcoma? A review of the National Cancer Data Base, Journal of Surgical Oncology, vol.116, issue.3, pp.384-390, 2017. ,
Characterization of side population in thyroid cancer cell lines: Cancer stem-like cells are enriched partly but not exclusively, Endocrinology, vol.148, issue.4, pp.1797-1803, 2007. ,
, , 2016.
, Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing, vol.126, pp.3417-3432
Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1?? expression is involved in prostate epithelial malignancy, Oncology Letters, vol.8, issue.3, pp.985-992, 2014. ,
,
Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development, Clinical Pharmacology & Therapeutics, vol.89, issue.4, pp.491-502, 2011. ,
Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line, Frontiers in Cell and Developmental Biology, vol.3, p.15, 2015. ,
Cellular senescence: from physiology to pathology, Nature Reviews Molecular Cell Biology, vol.15, issue.7, pp.482-496, 2014. ,
,
Cancer stem cell markers: premises and prospects, Biomarkers in Medicine, vol.9, issue.12, pp.1331-1373, 2015. ,
Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?, Bone, vol.62, pp.56-63, 2014. ,
,
Global gene expression profiling of human osteosarcomas reveals metastasisassociated chemokine pattern, Sarcoma, 2012. ,
Is ALDH1 a good method for definition of breast cancer stem cells?, Breast Cancer Research and Treatment, vol.123, issue.1, pp.109-111, 2010. ,
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, vol.445, issue.7123, pp.106-110, 2007. ,
,
Chemotherapy in a Mouse Model of Pancreatic Cancer, Cancer Research, vol.324, issue.5933, pp.1457-1461, 2010. ,
ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma, Cancer, vol.77, issue.1, pp.71-78, 1996. ,
Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells, Cell Death and Disease, vol.8, issue.7, 2017. ,
Tackling the cancer stem cells -what challenges do they pose?, Nature Reviews Drug Discovery, vol.13, issue.7, pp.497-512, 2014. ,
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial, The Lancet Oncology, vol.17, issue.8, pp.30096-30097, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01702092
Chromosomal Deficiencies and the Embryonic Development of Drosophila Melanogaster, Proceedings of the National Academy of Sciences of the United States of America, vol.23, issue.3, pp.133-137, 1937. ,
HypoxiaMediated Epigenetic Regulation of Stemness in Brain Tumor Cells, Stem Cells, vol.35, issue.6, pp.1468-1478, 2017. ,
Fibroblast activation and senescence in oral cancer, Journal of Oral Pathology & Medicine, 2016. ,
Neosis e a paradigm of selfrenewal in cancer, vol.29, pp.1084-1097, 2005. ,
Prognostic impact of ALDH1 in breast cancer: A story of stem cells and tumor microenvironment, Breast Cancer Research and Treatment, vol.123, issue.1, pp.97-108, 2010. ,
Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis, Cancer Letters, vol.271, issue.2, pp.306-313, 2008. ,
,
Identification and expansion of human colon-cancer-initiating cells, Nature, p.445, 2007. ,
Development of Ewing's Sarcoma from Primary Bone MarrowDerived Mesenchymal Progenitor Cells, Cancer Res, vol.65, issue.24, pp.11459-11468, 2005. ,
The Biology of Ewing sarcoma, Cancer Letters, vol.254, issue.1, pp.1-10, 2007. ,
EWS-FLI-1 expression triggers a ewing's sarcoma initiation program in primary human mesenchymal stem cells, Cancer Research, vol.68, issue.7, pp.2176-2185, 2008. ,
,
Overview of epigenetic mechanisms, Epigenetic mechanisms of gene regulation, 1996. ,
The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development, Oncogene, vol.32, issue.41, pp.4970-4980, 2013. ,
Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma, BMC Cancer, vol.14, p.606, 2014. ,
Genetic alterations in chondrosarcomasKeys to targeted therapies?, Cellular Oncology, vol.37, issue.2, pp.95-105, 2014. ,
,
DNA looping, Annu Rev Biochem, vol.61, pp.199-223, 1992. ,
,
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell, vol.77, issue.4, pp.90212-90219, 1994. ,
Intercellular junctions in Ewing sarcoma/primitive neuroectodermal tumor: additional evidence of epithelial differentiation, Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol.18, issue.11, pp.1403-1413, 2005. ,
,
Neoplastic stem cells: Current concepts and clinical perspectives, Critical Reviews in Oncology, vol.76, issue.2, pp.79-98, 2010. ,
,
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma, Nature Medicine, vol.23, issue.3, pp.386-395, 2017. ,
, , vol.2, pp.690-698, 2015.
Differential gene expression in leiomyosarcoma, Cancer, vol.98, issue.5, pp.1029-1038, 2003. ,
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha, Oncogene, vol.28, issue.45, pp.3949-3959, 2009. ,
,
Developmental fate and cellular maturity encoded in human regulatory DNA landscapes, Cell, vol.154, issue.4, pp.888-903, 2013. ,
,
The calpain system and cancer, Nature Reviews Cancer, vol.11, issue.5, pp.364-374, 2011. ,
EZH2 is essential for glioblastoma cancer stem cell maintenance, Cancer Research, vol.69, issue.24, pp.9211-9218, 2009. ,
Identification of cancer stem cells in Ewing's sarcoma, Cancer Res, vol.69, issue.5, pp.1776-1781, 2009. ,
Ovarian cancer side population defines cells with stem celllike characteristics and Mullerian Inhibiting Substance responsiveness, Proceedings of the National Academy of Sciences, vol.103, issue.30, pp.11154-11159, 2006. ,
,
Formation of an Active Tissue-Specific Chromatin Domain Initiated by Epigenetic Marking at the Embryonic Stem Cell Stage, Molecular and Cellular Biology, vol.25, issue.5, pp.1804-1820, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00187771
,
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways, Nature Reviews. Clinical Oncology, vol.8, issue.2, pp.97-106, 2011. ,
EZH2: biology, disease, and structurebased drug discovery, Acta Pharmacologica Sinica, vol.35, issue.2, pp.161-174, 2014. ,
Stem Cells, Cancer, and Cancer Stem Cells, Nature, vol.414, pp.105-111, 2001. ,
Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells, Molecular and Cellular Biochemistry, vol.394, issue.1, pp.23-30, 2014. ,
Pediatric osteosarcoma: An updated review, Indian Journal of Medical and Paediatric Oncology, 2017. ,
Detection and characterization of CD133+ cancer stem cells in human solid tumours, PLoS One, vol.3, issue.10, 2008. ,
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo, The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol.25, issue.6, pp.2022-2030, 2011. ,
,
, , 2007.
, Mesenchymal Stem Cell Features of Ewing Tumors. Cancer Cell, vol.11, issue.5, pp.421-429
Calpain-6 Deficiency Promotes Skeletal Muscle Development and Regeneration, PLoS Genetics, vol.9, issue.8, pp.1-11, 2013. ,
Calpain 6 is involved in microtubule stabilization and cytoskeletal organization, Molecular and Cellular Biology, vol.27, issue.7, pp.2548-61, 2007. ,
Cancer stem cells in osteosarcoma: Recent progress and perspective, Cancer Research, vol.7, issue.1, pp.1311-1328, 2011. ,
,
Calpain-6, a microtubule-stabilizing protein, regulates Rac1 activity and cell motility through interaction with GEF-H1, Journal of Cell Science, vol.124, pp.1214-1223, 2011. ,
terminology : the devil is in the details, Nature Publishing Group, vol.12, issue.11, pp.767-775, 2012. ,
Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas, Clin Cancer Res, vol.7, issue.7, pp.1998-2004, 2001. ,
Identification of Cancer Stem Cell-Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell Line, Cancer Research, vol.67, issue.8, pp.3716-3724, 2007. ,
Notch Promotes Radioresistance of Glioma Stem Cells Jialiang, Cancer Research, vol.9, issue.3, pp.231-242, 2011. ,
The metabolism of carcinoma cells, J Cancer Res, vol.9, pp.148-163, 1925. ,
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting ??-Ketoglutarate to 2-Hydroxyglutarate, Cancer Cell, vol.17, issue.3, pp.225-234, 2010. ,
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome, Nature Genetics, vol.39, issue.4, pp.457-466, 2007. ,
The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential, Cancer Cell, vol.28, issue.2, pp.198-209, 2015. ,
Reprogramming of central carbon metabolism in cancer stem cells, Biochimica et Biophysica Acta, issue.7, pp.1728-1738, 2017. ,
Side population cells isolated from mesenchymal neoplasms have tumor initiating potential, Cancer Research, vol.67, issue.17, pp.8216-8222, 2007. ,
Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC, Oncology Letters, vol.13, issue.4, pp.2237-2243, 2017. ,
,
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of ?-ketoglutarate-dependent dioxygenases, Cancer Cell, vol.19, issue.1, pp.17-30, 2011. ,
Warburg effect or reverse warburg effect? a review of cancer metabolism, Oncology Research and Treatment, vol.38, issue.3, pp.117-122, 2015. ,
Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells, Cancer Science, vol.102, issue.10, pp.1774-1781, 2011. ,
Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro, Biochemical and Biophysical Research Communications, vol.391, issue.1, pp.1062-1066, 2010. ,
Autophagy regulates the stemness of cervical cancer stem cells, Biologics: Targets and Therapy, vol.11, pp.71-79, 2017. ,
, , 2017.
, Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer. Molecular and Cellular Biology, pp.352-369
Transforming growth factor ?1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma, Stem Cells, vol.31, issue.3, pp.433-446, 2013. ,
, , vol.71, pp.6061-6072, 2012.
miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and selfrenewal capacity, Molecular Medicine Reports, vol.15, issue.4, pp.1631-1637, 2017. ,
,
, ANNEXE 1
, Liste des présentations des travaux de recherche Février 2015 : Présentation orale
, Super Besse, France " Calpain-6 expression identifies a stem cell population in osteosarcoma, Congrès des Journées Françaises des Tissus Minéralisés (JFBTM), 2015.
, Présentation Orale (10 min) PhD training course de l'European Calcified Tissue Society (ECTS), Oxford, Royaume-Unis "Calpain-6 acts as a cell fate determinant and identifies osteosarcoma stem cells, Prix reçu: New investigator award Juillet, 2016.
La calpaïne-6 identifie des cellules souche des ostéosarcomes, Groupe Sarcome Français), 2017. ,
Calpaïne-6 : Biomarqueur des cellules souche des ostéosarcomes ,